Pages that link to "Q52507296"

The following pages link to Demyelination in a transgenic mouse: a model for multiple sclerosis. (Q52507296):

Displaying 43 items.

• Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse (Q28115036) (← links)
• A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease (Q28256953) (← links)
• Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development (Q28506188) (← links)
• Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene (Q28509913) (← links)
• Deimination restores inner retinal visual function in murine demyelinating disease (Q30533881) (← links)
• Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models (Q30831649) (← links)
• Different proteolipid protein mutants exhibit unique metabolic defects (Q33608057) (← links)
• Distinct phenotypes associated with increasing dosage of the PLP gene: implications for CMT1A due to PMP22 gene duplication (Q33787351) (← links)
• Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination (Q34126797) (← links)
• Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a review (Q34158137) (← links)
• Increased Plp1 Gene Expression Leads to Massive Microglial Cell Activation and Inflammation Throughout the Brain (Q34159466) (← links)
• Evaluation of a transgenic mouse model of multiple sclerosis with noninvasive methods. (Q34840430) (← links)
• Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. (Q36276665) (← links)
• Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis (Q36683082) (← links)
• Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS. (Q36832884) (← links)
• Experimental models of spontaneous autoimmune disease in the central nervous system. (Q36849410) (← links)
• Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system (Q36990484) (← links)
• Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis (Q37350252) (← links)
• Genetic approaches to study glial cells in the rodent brain. (Q37967602) (← links)
• Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities (Q38689502) (← links)
• The proteolipid protein gene (Q40402411) (← links)
• Oligodendrocytes and myelin. (Q40518549) (← links)
• The proteolipid protein gene: double, double, ... and trouble. (Q42587278) (← links)
• Peptidylarginine deiminase: a candidate factor in demyelinating disease (Q44027704) (← links)
• Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis. (Q44495415) (← links)
• Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders. (Q45230647) (← links)
• Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis (Q46160733) (← links)
• Adhesion and clustering of charge isomers of myelin basic protein at model myelin membranes (Q47411224) (← links)
• The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient (Q47847109) (← links)
• Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases (Q48147146) (← links)
• Deimination level and peptidyl arginine deiminase 2 expression are elevated in astrocytes with increased incubation temperature. (Q48266377) (← links)
• Mouse models of myelin diseases (Q48357457) (← links)
• Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. (Q48380864) (← links)
• Three-dimensional structure of myelin basic protein. I. Reconstruction via angular reconstitution of randomly oriented single particles (Q48800366) (← links)
• Animal models of demyelination (Q48972525) (← links)
• The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. (Q52168267) (← links)
• Highly basic myelin and oligodendrocyte proteins analyzed by NEPHGE-two-dimensional gel electrophoresis: recognition of novel developmentally regulated proteins. (Q52174403) (← links)
• Transgenic and natural mouse models of proteolipid protein (PLP)-related dysmyelination and demyelination. (Q52518078) (← links)
• Partitioning of myelin basic protein into membrane microdomains in a spontaneously demyelinating mouse model for multiple sclerosisThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB — Membrane Proteins in He (Q57374579) (← links)
• Human proteolipid protein (PLP) mediates winding and adhesion of phospholipid membranes but prevents their fusion (Q57898448) (← links)
• Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependent (Q71343402) (← links)
• The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease (Q77602143) (← links)
• The Role of Deimination in Regenerative Reprogramming of Neurons (Q90552933) (← links)